Results 141 to 150 of about 57,164 (280)
Background: Despite increasing concerns about the association between remdesivir and bradycardia in severe coronavirus disease 2019 (COVID-19) patients receiving remdesivir, information on its clinical course and precipitating factors is limited. Our aim
Yan-Zuo Chen+4 more
doaj
COVID‐19‐Related Croup With Acute Respiratory Failure
The Kaohsiung Journal of Medical Sciences, EarlyView.
Chi‐Kai Hsu+3 more
wiley +1 more source
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon+4 more
wiley +1 more source
A study of effect of remdesivir on mortatlity and hospital stay of moderate to severe cases of COVID-19/ severe acute respiratory illness in North Karnataka region [PDF]
Background: As the epidemic that started at Wuhan spread globally many agents with antiviral activity were evaluated for the treatment of coronavirus disease. Many agents were claimed to be “Game changer” in the management of covid.
Habibulla D. Attar+4 more
doaj
In transplant recipients with prior Omicron infection, neutralizing antibodies against JN.1 were limited and often absent 1 year later. However, robust and durable CD4⁺ T‐cell responses were consistently observed, suggesting that cellular immunity may offer sustained protection against emerging SARS‐CoV‐2 variants, despite modest antibody responses ...
Victor H. Ferreira+11 more
wiley +1 more source
Remdesivir and its antiviral activity against COVID-19: A systematic review
Background: The aim of this study was to summarize the antiviral activities of remdesivir against SARS-CoV-2, the causative agent of COVID-19. Methods: Available publications were systematically explored on some databases and gray literature was examined.
Andri Frediansyah+4 more
doaj
ABSTRACT Cognitive impairment following COVID‐19 infection is common and risk factors remain poorly understood. Sleep disturbance increases risk of cognitive impairment in the general population, and sleep disturbance is common after COVID‐19. While prior literature has extensively explored the relationship between sleep and cognition, few studies have
Ayah I. Eltoum+4 more
wiley +1 more source
Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective [PDF]
Zainab Gandhi+2 more
openalex +1 more source
Remdesivir: a pendulum in a pandemic [PDF]
Schwartz, Ilan S+2 more
openaire +2 more sources
Theaflavins demonstrate significant pharmacological effects on various chronic diseases, while low availability and stability. In vitro synthesis methods, such as enzymatic oxidation and nonenzymatic synthesis, can significantly enhance the production of theaflavins, but industrialization still faces some challenges.
Shaolong Du, Junyi Chang, Zhimei Zhou
wiley +1 more source